1 tion of the ventricles. This uncoordinated ventricular contraction further reduces the
pumping efficiency of an already weakened heart muscle in CHF patients. It is estimated that …

Background: Cardiac resynchronization therapy (CRT) improves symptoms, left ventricular
ejection fraction (LVEF) and survival in patients with heart failure and wide QRS, however …

Objectives: We sought to determine the effects of cardiac resynchronization therapy (CRT) in
New York Heart Association (NYHA) functional class II heart failure (HF) and NYHA …

Aims To determine what proportion of patients with heart failure are eligible for cardiac
resynchronization therapy (CRT). Methods and results Eligibility criteria from the trials …

Background: Cardiac resynchronization therapy (CRT) is currently being tested as an
adjunct therapy to treat heart failure (HF). The VENTAK CHF/CONTAK CD study, a …

Many diagnostic and therapeutic advances have been reached for congestive heart failure
(HF). However, despite clinical improvement and longer survival conferred by new …

Background Heart failure is considered an epidemic of the modern era. In selected
candidates on optimal medical therapy, cardiac resynchronization therapy (CRT) has …

Background: Cardiac resynchronisation therapy (CRT) is a promising new treatment for
patients with heart failure and cardiac dyssynchrony. The CARE‐HF study is a …

The National Institute for Health and Clinical Excellence (NICE) published recently the
guidance for cardiac resynchronisation therapy (CRT) for the treatment of heart failure which …

Newer non-pharmacological therapies for heart failure are being evaluated for patients of
congestive heart failure (CHF). Mechanical support with left ventricular assist devices and …